Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist

Slides:

Advertisements

Similar presentations

First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids Mathieu Luyckx, M.D., Jean-Luc Squifflet, M.D., Ph.D., Pascale Jadoul,

Advertisements

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis

Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous.

Complete septate uterus with longitudinal vaginal septum

Successful use of magnetic resonance–guided focused ultrasound surgery to relieve symptoms in a patient with symptomatic focal adenomyosis Sang-Wook.

Edward G. Hughes, M.B., F.R.C.S.(C.), Deirdre DeJean, M.Sc.

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective,

Infertility evaluation and treatment among women in the United States

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Amber Samuel, M. D. , Fiona M. Fennessy, M. D. , Ph. D. , Clare M. C

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor.

1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for.

Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center Min Zhou, M.D., Ph.D., Jin-Yun.

Michael M. Alper, M.D. Fertility and Sterility

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist.

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Kae-Yng Ou, M. D. , Yu-Chieh Chen, M. D. , Shih-Cheng Hsu, M. D

A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin)

Medical treatment of ectopic pregnancy: a committee opinion

Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo- controlled, double-blind, randomized trial Tasuku Harada, M.D., Mikio.

Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing.

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Transurethral partial cystectomy and laparoscopic reconstruction for the management of bladder endometriosis See-Tong Pang, M.D., Ph.D., Angel Chao,

Florid endometriosis in a postmenopausal woman

Oocyte cryopreservation

Conservative surgical management for diffuse uterine adenomyosis

Efficacy of tibolone as “add-back therapy” in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids Edward.

Chao-Chin Hsu, M. D. , Ph. D. , Hsin-Chih Kuo, Ph. D

Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review Seema Menon, M.D., John.

Robert F. Casper, M.D. Fertility and Sterility

Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain Mohamed A. Bedaiwy,

Gadolinium radiologic contrast is a useful alternative for hysterosalpingography in patients with iodine allergy Dorette Noorhasan, M.D., Michael J.

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for.

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

Clomiphene citrate at 50: the dawning of assisted reproduction

Treatment of Ovarian Hyperstimulation Syndrome Utilizing a Dopamine Agonist and Gonadotropin Releasing Hormone antagonist N. Rollene, M. Amols, S. Hudson,

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Retrieval of immature oocytes after chemotherapy for Hodgkin's disease and prolonged ovarian down-regulation with gonadotropin-releasing hormone agonist

Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,

Eva Balkenende, Taghride Dahhan, M. D. , Fulco van der Veen, M. D, Ph

Sung Hoon Kim, M. D. , Jeong Kon Kim, M. D. , Hee Dong Chae, M. D

Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists José M. López, M.D., Eveline.

Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series Nanette L. Rollene,

Effectiveness of highly purified human menopausal gonadotropin vs

A case of giant cystic adenomyosis

Effect of gonadotropin-releasing-hormone-induced hypogonadism on insulin action as assessed by euglycemic clamp studies in men Subodhsingh Chauhan, M.D.,

Three-dimensional computed tomography combined with hysterosalpingography is useful for both diagnosis and treatment of iatrogenic diverticulum of the.

Fertility and Sterility: an evaluation

Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.

Sedigheh Borna, M.D., Azita Nasery, M.D. Fertility and Sterility

Maternal and female fetal virilization caused by pregnancy luteomas

Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin- releasing hormone agonist short regimen on alternate days and an antagonist.

Current evaluation of amenorrhea

Genetic evaluation procedures at sperm banks in the United States

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Serum anti-Mullerian hormone dynamics during stimulated cycles by aromatase inhibitor anastrozole and clomiphene citrate in women with infertility H.-H.

Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists

Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study Ahmed Badawy, M.D., Aboubakr.

The gonadotropin-releasing hormone (GnRH)-1 gene, the GnRH receptor gene, and their promoters in patients with idiopathic hypogonadotropic hypogonadism.

In vitro sildenafil citrate use as a sperm motility stimulant

What if deep endometriotic nodules and uterine adenomyosis were actually two forms of the same disease? Jacques Donnez, M.D., Ph.D., Marie-Madeleine.

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Endometrial polyps affect uterine receptivity

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing.

In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation

Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment Daniel Bodri, M.D., M.Sc.,

Presentation transcript:

Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist Fuminori Kimura, M.D., Ph.D., Kentaro Takahashi, M.D., Ph.D., Koichi Takebayashi, M.D., Ph.D., Mutsuko Fujiwara, M.D., Nobuyuki Kita, M.D., Ph.D., Yoichi Noda, M.D., Ph.D., Nobuhiro Harada, Ph.D. Fertility and Sterility Volume 87, Issue 6, Pages 1468.e9-1468.e12 (June 2007) DOI: 10.1016/j.fertnstert.2006.09.010 Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

FIGURE 1 Magnetic resonance images of uterine adenomyosis. All sections are magnetic resonance images of adenomyosis. (A, C) Pretreatment with aromatase inhibitor and GnRH agonist. (B, D) Posttreatment (after 80 d) with aromatase inhibitor and GnRH agonist. (A, B) Sagittal section. (C, D) Axial section. Kimura. Aromatase inhibitor for adenomyosis. Fertil Steril 2007. Fertility and Sterility 2007 87, 1468.e9-1468.e12DOI: (10.1016/j.fertnstert.2006.09.010) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions